Immunization of Mice with Anthrax Protective Antigen Limits Cardiotoxicity but Not Hepatotoxicity Following Lethal Toxin Challenge
Protective immunity against anthrax is inferred from measurement of vaccine antigen-specific neutralizing antibody titers in serum samples. In animal models, in vivo challenges with toxin and/or spores can also be performed. However, neither of these approaches considers toxin-induced damage to spec...
Main Authors: | T. Scott Devera, Dawn K. Prusator, Sunil K. Joshi, Jimmy D. Ballard, Mark L. Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-06-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/7/7/2371 |
Similar Items
-
Anthrax Toxin Characterization
by: Jiří Patočka, et al.
Published: (2002-01-01) -
Cellular and physiological effects of anthrax exotoxin and its relevance to disease
by: David Edward Lowe, et al.
Published: (2012-06-01) -
Development of a New Cell-Based AP-1 Gene Reporter Potency Assay for Anti-Anthrax Toxin Therapeutics
by: Weiming Ouyang, et al.
Published: (2023-08-01) -
Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies
by: Dante A. Suffredini, et al.
Published: (2015-12-01) -
Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination
by: Christopher K. Cote, et al.
Published: (2015-08-01)